Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury.

Legos JJ, McLaughlin B, Skaper SD, Strijbos PJ, Parsons AA, Aizenman E, Herin GA, Barone FC, Erhardt JA.

Eur J Pharmacol. 2002 Jun 28;447(1):37-42.

PMID:
12106800
2.

Neuronal protein kinase signaling cascades and excitotoxic cell death.

Skaper SD, Facci L, Strijbos PJ.

Ann N Y Acad Sci. 2001 Jun;939:11-22. Review.

PMID:
11462762
3.

Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia.

Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, Badger AM, Legos JJ, Erhardt JA, Ohlstein EH, Hunter AJ, Harrison DC, Philpott K, Smith BR, Adams JL, Parsons AA.

Med Res Rev. 2001 Mar;21(2):129-45. Review.

PMID:
11223862
4.

[Protective effects of N-methyl-D-aspartate against neuronal damages].

Okuda H, Ogita K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2002 Oct;22(5):153-8. Review. Japanese.

PMID:
12451685
5.

Inhibition of p38 MAP kinase as a therapeutic strategy.

Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL.

Immunopharmacology. 2000 May;47(2-3):185-201. Review.

PMID:
10878289
6.

Toward the development of strategies to prevent ischemic neuronal injury. In vitro studies.

Marini AM, Spiga G, Mocchetti I.

Ann N Y Acad Sci. 1997 Oct 15;825:209-19. Review.

PMID:
9369988
7.

Therapeutic potential of anti-inflammatory drugs in focal stroke.

Barone FC, Parsons AA.

Expert Opin Investig Drugs. 2000 Oct;9(10):2281-306. Review.

PMID:
11060807
8.

Cell signaling in NMDA preconditioning and neuroprotection in convulsions induced by quinolinic acid.

Severino PC, Muller Gdo A, Vandresen-Filho S, Tasca CI.

Life Sci. 2011 Oct 10;89(15-16):570-6. doi: 10.1016/j.lfs.2011.05.014. Epub 2011 Jun 13. Review.

PMID:
21683718
9.

NMDA antagonists: their role in neuroprotection.

Small DL, Buchan AM.

Int Rev Neurobiol. 1997;40:137-71. Review. No abstract available.

PMID:
8989620
10.

Excitotoxicity: perspectives based on N-methyl-D-aspartate receptor subtypes.

Lynch DR, Guttmann RP.

J Pharmacol Exp Ther. 2002 Mar;300(3):717-23. Review.

11.

P38 MAP kinase inhibitors: evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes.

Natarajan SR, Doherty JB.

Curr Top Med Chem. 2005;5(10):987-1003. Review.

PMID:
16178742
12.

Excitotoxicity and selective neuronal loss in epilepsy.

Meldrum BS.

Brain Pathol. 1993 Oct;3(4):405-12. Review.

PMID:
8293196
13.

The rapid effects of estrogen are implicated in estrogen-mediated neuroprotection.

Linford N, Wade C, Dorsa D.

J Neurocytol. 2000 May-Jun;29(5-6):367-74. Review.

PMID:
11424953
14.

Techniques for assessing neuroprotective drugs in vitro.

Goldberg MP, Strasser U, Dugan LL.

Int Rev Neurobiol. 1997;40:69-93. Review. No abstract available.

PMID:
8989617

Supplemental Content

Support Center